Nuha A. ElSayed
Nuha A. ElSayed publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and Epidemiology, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Diabetes Management and Education.
- World rank
- #2,508 of 7,710,434 ranked researchers
- Rank in United States
- #909 of 1,627,098
- Works
- 114
- Citations
- 23k
- Citations per work
- 199.7
What does Nuha A. ElSayed research?
Nuha A. ElSayed's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8675.0%
- Medicine8675.0%
- Everything else2118.8%
- Life Sciences76.2%
- 1Endocrinology, Diabetes and Metabolism57% of their works
- 2Genetics6% of their works
- 3Epidemiology5% of their works
- 4Surgery5% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Physiology3% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes and associated disorders
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet and metabolism studies
- Chronic Disease Management Strategies
Which keywords describe Nuha A. ElSayed's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Primary Care.
- Multimorbidity
- Low-Carbohydrate Diet
- Obesity
- Genetics
- Epidemiology
- Hyperglycemia
- Self-Management
- Type 2 Diabetes
- Primary Care
- Continuous Glucose Monitoring
- Cardiovascular Disease
- Insulin Therapy
- Glycemic Control
- Diabetes
- Type 1 Diabetes
- Hypoglycemia
- Cardiovascular Outcomes
- Depression
- Critical Care
- Metabolic Syndrome
- Autoimmunity
- Insulin Resistance
- Ketogenic Diet
- Chronic Conditions
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Glycemic Control1434 topics
- Insulin Therapy1093 topics
- Diabetes953 topics
- Cardiovascular Disease612 topics
- Type 1 Diabetes612 topics
- Continuous Glucose Monitoring431 topic
- Hypoglycemia431 topic
- Primary Care422 topics
- Cardiovascular Outcomes361 topic
- Type 2 Diabetes361 topic
- Depression341 topic
- Self-Management341 topic
- Critical Care301 topic
- Hyperglycemia301 topic
- Metabolic Syndrome272 topics
- Epidemiology262 topics
- Autoimmunity181 topic
- Genetics181 topic
- Insulin Resistance181 topic
- Obesity181 topic
- Ketogenic Diet91 topic
- Low-Carbohydrate Diet91 topic
- Chronic Conditions81 topic
- Multimorbidity81 topic
Where does Nuha A. ElSayed work?
Nuha A. ElSayed's main affiliation in the publication record is Harvard University, United States.
How many publications and citations does Nuha A. ElSayed have?
OpenAlex counts 114 works and 22,768 citations for Nuha A. ElSayed, an h-index of 65, ranking #2,508 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nuha A. ElSayed. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.